Fighting Falsified Medicines – The Novartis Way

Continuing our series of articles on the strategic perspectives of leading brands in their fight against fakes, this month we turn our attention to Novartis, one of the largest pharmaceutical companies in the world, and the fourth largest in terms of revenue in 2022.